Trials / Terminated
TerminatedNCT03339388
Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stone Disease
Multi-Center Feasibility Study of Enhanced Lithotripsy System (ELS) in The Treatment of Urinary Stone Disease
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Avvio Medical · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a single arm, multi-center study to assess the safety and efficacy of a form of extracorporeal lithotripsy, called the Enhanced Lithotripsy System, to treat urinary stones.
Detailed description
This is a single arm, multi-center study to assess the safety and efficacy of a form of extracorporeal lithotripsy, called the Enhanced Lithotripsy System, to treat urinary stones. Subjects will be treated up to 2 times with the Enhanced Lithotripsy System and followed for 90 days after the last treatment session.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Enhanced Lithotripsy System | Stone treatment with the Enhanced Lithotripsy System |
Timeline
- Start date
- 2017-12-08
- Primary completion
- 2018-07-10
- Completion
- 2022-10-05
- First posted
- 2017-11-13
- Last updated
- 2024-04-17
Locations
4 sites across 1 country: Australia
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03339388. Inclusion in this directory is not an endorsement.